Spero Therapeutics Statistics
Total Valuation
SPRO has a market cap or net worth of $71.05 million. The enterprise value is $22.32 million.
| Market Cap | 71.05M |
| Enterprise Value | 22.32M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRO has 58.23 million shares outstanding. The number of shares has increased by 9.06% in one year.
| Current Share Class | 58.23M |
| Shares Outstanding | 58.23M |
| Shares Change (YoY) | +9.06% |
| Shares Change (QoQ) | +1.20% |
| Owned by Insiders (%) | 4.00% |
| Owned by Institutions (%) | 21.07% |
| Float | 46.72M |
Valuation Ratios
The trailing PE ratio is 9.55.
| PE Ratio | 9.55 |
| Forward PE | n/a |
| PS Ratio | 1.51 |
| Forward PS | n/a |
| PB Ratio | 1.60 |
| P/TBV Ratio | 1.61 |
| P/FCF Ratio | 3.63 |
| P/OCF Ratio | 3.63 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 3.02 |
| EV / Sales | 0.47 |
| EV / EBITDA | n/a |
| EV / EBIT | 3.38 |
| EV / FCF | 1.14 |
Financial Position
The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.05.
| Current Ratio | 6.12 |
| Quick Ratio | 6.03 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.25 |
| Debt / FCF | 0.10 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 19.17% and return on invested capital (ROIC) is 72.44%.
| Return on Equity (ROE) | 19.17% |
| Return on Assets (ROA) | 7.19% |
| Return on Invested Capital (ROIC) | 72.44% |
| Return on Capital Employed (ROCE) | 14.91% |
| Weighted Average Cost of Capital (WACC) | 12.06% |
| Revenue Per Employee | $1.88M |
| Profits Per Employee | $295,320 |
| Employee Count | 25 |
| Asset Turnover | 0.82 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SPRO has paid $261,000 in taxes.
| Income Tax | 261,000 |
| Effective Tax Rate | 3.41% |
Stock Price Statistics
The stock price has decreased by -33.33% in the last 52 weeks. The beta is 1.48, so SPRO's price volatility has been higher than the market average.
| Beta (5Y) | 1.48 |
| 52-Week Price Change | -33.33% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 2.28 |
| Relative Strength Index (RSI) | 35.31 |
| Average Volume (20 Days) | 756,212 |
Short Selling Information
The latest short interest is 1.51 million, so 2.60% of the outstanding shares have been sold short.
| Short Interest | 1.51M |
| Short Previous Month | 2.11M |
| Short % of Shares Out | 2.60% |
| Short % of Float | 3.24% |
| Short Ratio (days to cover) | 0.73 |
Income Statement
In the last 12 months, SPRO had revenue of $47.00 million and earned $7.38 million in profits. Earnings per share was $0.13.
| Revenue | 47.00M |
| Gross Profit | 26.47M |
| Operating Income | 6.61M |
| Pretax Income | 7.64M |
| Net Income | 7.38M |
| EBITDA | n/a |
| EBIT | 6.61M |
| Earnings Per Share (EPS) | $0.13 |
Balance Sheet
The company has $50.77 million in cash and $2.04 million in debt, with a net cash position of $48.73 million or $0.84 per share.
| Cash & Cash Equivalents | 50.77M |
| Total Debt | 2.04M |
| Net Cash | 48.73M |
| Net Cash Per Share | $0.84 |
| Equity (Book Value) | 44.20M |
| Book Value Per Share | 0.76 |
| Working Capital | 43.16M |
Cash Flow
| Operating Cash Flow | 19.58M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 19.58M |
| FCF Per Share | $0.34 |
Margins
Gross margin is 56.31%, with operating and profit margins of 14.07% and 15.71%.
| Gross Margin | 56.31% |
| Operating Margin | 14.07% |
| Pretax Margin | 16.26% |
| Profit Margin | 15.71% |
| EBITDA Margin | n/a |
| EBIT Margin | 14.07% |
| FCF Margin | 41.66% |
Dividends & Yields
SPRO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.06% |
| Shareholder Yield | -9.06% |
| Earnings Yield | 10.39% |
| FCF Yield | 27.56% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | -20.87% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SPRO has an Altman Z-Score of -0.68 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.68 |
| Piotroski F-Score | 7 |